Scott A. Gerber

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Bradley N. Mills · 5 shared papers, 2020–2025 · strength 0.77
   • Paper Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (M… DOI 10.1021/acsomega.2c07080↗
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
2. David C. Linehan · 4 shared papers, 2020–2025 · strength 0.55
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
3. Tara G Vrooman · 2 shared papers, 2022–2025 · strength 0.35
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
4. Booyeon Julia Han · 3 shared papers, 2020–2022 · strength 0.34
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
5. Joseph D. Murphy · 3 shared papers, 2020–2022 · strength 0.34
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
6. Jian Ye · 2 shared papers, 2020–2025 · strength 0.32
   • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗
   • Paper Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Trea… DOI 10.1158/2326-6066.cir-19-0373↗
7. Jian Ye · 2 shared papers, 2020–2022 · strength 0.24
   • Paper Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor effica… DOI 10.1136/jitc-2022-004784↗
   • Paper Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinom… DOI 10.1080/08820139.2020.1765795↗
8. Debamitra Chakraborty · 1 shared paper, 2023 · strength 0.22
   • Paper Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (M… DOI 10.1021/acsomega.2c07080↗
9. Roman Sobolewski · 1 shared paper, 2023 · strength 0.22
   • Paper Development of Terahertz Imaging Markers for Pancreatic Ductal Adenocarcinoma using Maximum A Posteriori Probability (M… DOI 10.1021/acsomega.2c07080↗
10. Angela L. Hughson · 1 shared paper, 2025 · strength 0.21
    • Paper Blockade of LIF and PD-L1 Enhances Chemotherapy in Preclinical PDAC Models. DOI 10.3390/cancers17020204↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.